ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SPI Spire Healthcare Group Plc

185.00
0.00 (0.00%)
25 Apr 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Spire Healthcare Group Plc LSE:SPI London Ordinary Share GB00BNLPYF73 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.00% 185.00 609,290 16:35:09
Bid Price Offer Price High Price Low Price Open Price
185.60 186.00 187.60 184.80 187.00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Health & Allied Services,nec 1.51B 25.4M 0.0631 29.38 745.09M
Last Trade Time Trade Type Trade Size Trade Price Currency
16:42:14 O 75,343 185.1666 GBX

Spire Healthcare (SPI) Latest News

Spire Healthcare (SPI) Discussions and Chat

Spire Healthcare Forums and Chat

Date Time Title Posts
28/3/202517:18Spire Health1,692
26/5/202107:36At ladt1
08/11/202011:22Unloved and Underappreciated-
24/10/202017:47Sunday Times view-
15/1/201713:48Spice Holdings PLC1,547

Add a New Thread

Spire Healthcare (SPI) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type

Spire Healthcare (SPI) Top Chat Posts

Top Posts
Posted at 27/4/2025 09:20 by Spire Healthcare Daily Update
Spire Healthcare Group Plc is listed in the Health & Allied Services,nec sector of the London Stock Exchange with ticker SPI. The last closing price for Spire Healthcare was 185p.
Spire Healthcare currently has 402,751,824 shares in issue. The market capitalisation of Spire Healthcare is £746,701,882.
Spire Healthcare has a price to earnings ratio (PE ratio) of 29.38.
This morning SPI shares opened at 187p
Posted at 23/3/2025 09:33 by masurenguy
Simply Wall Street
Sun 23 Mar 2025

Spire Healthcare Group: SPI
Last Price: £1.74

* Consensus EPS estimates fall by 15%
* The consensus outlook for fiscal year 2025 has been updated.
* 2025 EPS estimate fell from UK£0.132 to UK£0.112 per share.
* Revenue forecast steady at UK£1.60b.
* Net Inc forecast to grow 81% next year vs 28% growth forecast for Healthcare industry in the UK.
* Consensus price target down from UK£3.01 to UK£2.91.
* Share price was steady at UK£1.74 over the past week.
Posted at 15/3/2025 11:02 by quick thinker
I saw that, igoe. Those videos are interesting to get some alternative views from various fund managers. I'd like to hear Christopher Mills take on it again. Spire was his favourite share for 2025 with his expectations, if I recall, being that earnings would grow substantially and debt would reduce significantly over the next couple of years. He also noted the property valuation point that Paul Hill pointed out and that there may be external interest from India to take over the business. I haven't studied the results in details but I'd be interested to dig into the debt and earnings figures to see if Christopher's view on these appear to stack up.
Posted at 14/3/2025 17:34 by igoe104
I see paul Hill from vox markets has taken up a position in SPI, he mentioned the assets are worth a hell of alot more than the current shareprice...
Posted at 10/3/2025 10:48 by tsmith2
JPMorgan cuts Spire Healthcare price target to 309 (321) pence - 'overweight'very modest TP reduction post update. market reaction on other hand has been brutal.
Posted at 07/3/2025 12:52 by masurenguy
Spire Healthcare’s profit to be hit by £30m costs increase
Shares in private healthcare provider fall sharply as looming national insurance rise and higher energy prices take toll

Rising employment and energy costs as well as a shift from self-pay to private insurance is set to hit profits at Spire Healthcare by about £30m this year, triggering a sell-off in its shares. Alongside mixed full-year results on Thursday, the FTSE 250 private healthcare company forecast adjusted profits of between £270m and £285m this year, below the City’s forecasts. Spire said this was because of a combination of April’s rise in employers’ national insurance contributions, the national minimum wage, “payor mix changes” and increased energy costs.

The FTSE 250 company said that it expected to offset about £10m of these costs this year, including by accelerating cost savings and self-pay price changes. An efficiency programme, announced two years ago, including digitising administration, is “delivering ahead of plan” and will be sped-up. Spire therefore expects savings of at least £30m this year, about £10m above its initial plans. It has also expanded its 2024 to 2026 cumulative savings target to £80m, from £60m. But with its profit outlook for this year below the consensus forecast of analysts, shares in Spire were down 16%, or 36p, to close at 188½p on the London Stock Exchange. Despite today’s share declines, the stock is up about 70% over the past five years, although it remains below the 250p takeover offer from Ramsay Health Care, an Australian competitor, in 2021 which, unusually, was voted down by shareholders.

Complete article:
Posted at 07/3/2025 12:45 by ricky46
£1.4 billion of freehold property, this is more like a property fund, there spending £100 million a year on capex too, basically at this share price the whole business is valued at zero..... that's just a crazy valuation
Posted at 06/3/2025 13:44 by ricky46
The share price is covered by the land and property alone, so your basically getting the business for free, that's what it looks like in the accounts and that's why its touted as a bid target, the NI increases were known costs before today, so surely today is just a massive over reaction, if there's potential bidders out there now seems like a good time to pounce!
Posted at 06/3/2025 08:27 by carcosa
The negatives:

National Insurance (NI) & Minimum Wage (NMW) are expected to add £18m–£20m annually to costs, with an FY25 in-year impact of £13m–£15m. Though £10m of savings are planned, some cost pressures will still impact margins.

The energy hedge expired in Q4 FY24, leading to higher energy expenses in FY25.
Long-term solar panel installations may reduce costs, but short-term expenses will rise​.

Inflation-driven wage demands may outpace Spire’s ability to mitigate through efficiency savings.

Increased competition for healthcare professionals could push up hiring & retention costs.

NHS revenue grew 8.8% YoY, making up ~30% of total revenue.

Private Medical Insurance (PMI) and Self-Pay (SP) are higher-margin segments, but more patients are switching from Self-Pay to PMI, potentially lowering margins​

The government’s approach to NHS funding could impact Spire’s future revenues.

PMI insurers are growing market share, meaning negotiating power may shift in their favour, putting downward pressure on pricing.
Posted at 06/3/2025 07:13 by masurenguy
Spire Healthcare reports results for the year ended 31 December 2024
Good financial results, strong patient satisfaction and all core metrics in line with guidance

Delivered guidance, mitigating mix and cost

(Unless otherwise stated, y/y growth metrics and margin expansion metrics are presented on a comparable basis1)

· Revenue growth of 6.2% y/y; comprised of 5.5% y/y in Hospitals and 15.0% y/y from Primary Care services.

· Payor mix evolving with stronger performance in NHS revenue, up 8.8% y/y and Private patient revenue (PMI + Self-Pay) up 4.3% y/y.

· Group adj. EBITDA grew 9.0% to £260.0m. Reflecting price, acuity and cost saving benefits which provided mitigation to H2 impacts from payor mix changes and energy hedge roll off.

· Group adj. EBITDA margin of 17.2%. Within this, we saw good expansion in Hospitals margin, up 30 bps y/y to 18.0% and very strong expansion in Primary Care margin up 340 bps to 8.5%.

· Operating profit up 9.0% y/y on a stated basis to £137.5m, including adjusting items of £(11.9)m largely related to the transformation programme and previously disclosed remediation.

· ROCE(6) increased to 8.2% (FY23: 7.5%).

· Recommended final dividend of 2.3 pence per ordinary share (FY23: 2.1 pence per ordinary share).

Strong strategic delivery of growth and efficiency

· Cost savings accelerated: delivering >£20m in FY24 through procurement standardisation, automating booking procedures, Patient Support Centres and implementing staffing models to reduce agency use.

· Vita outperforming management expectations with revenue of £107m and EBITDA £11m.

· Three new Primary Care clinics opened. Meeting more patient needs and driving referrals to nearby Hospitals.

· Responded to NHS demand. Increasing eRS slots and driving 20% y/y volume growth in Q4, with high Orthopaedic mix of over 60%.

· Record levels of clinical permanent employment, with turnover at an all-time low of 11.5%.

· Leading on quality. Average length of stay reduced for hip and knee procedures, Patient Safety Incident Response Framework implemented and Patient Survey showed 97% rated their experience as good / very good (up 1% from prior year).

Outlook and current trading

We are confident in delivering mid-single digit y/y percentage Group revenue growth in FY25. This will be driven by the combination of structural market expansion, good growth prospects in Hospitals and the growing demand for our Primary Care services.

We continue to see evolution in the underlying mix by payor group. We anticipate strong overall demand for services, with growth in Private patients and a continued strategic partnership with the NHS. The growth in Private patients will be driven by Private Medical Insurers (PMIs), where they are reporting strong increases in policies written, which in turn will result in more activity; and working age patients increasingly being covered. The latter means we anticipate continued Self Pay (SP) switching to PMI, where our drivers for growth are focused on average revenue per case (ARPC) and mix management. As a reminder, share price procedures are our highest margin activities, followed by PMI, and NHS funded admissions.

Cost savings are already delivering ahead of plan and we intend to accelerate this further. With new savings of at least £30m in FY25, which are c£10m above our original plans. At the same time we are increasing our FY24-26 cumulative savings target to £80m (was previously £60m).

We expect a £(30)m EBITDA impact in FY25 as a result of National Insurance (NI) and National Minimum Wage (NMW), payor mix changes and the roll off of our energy hedge. We expect NI and NMW to add £18-20 million to operating costs on an annualised basis before mitigation, making the FY25 in-year impact c£13-15m. In FY25 we believe we can offset c£10m of NI, NMW, payor mix and energy costs combined through accelerated cost savings, driving high margin acuity mix and self-pay pricing changes. Bringing this together, we are guiding to FY25 adjusted EBITDA for the Group to be in the range of £270m to £285m.

We remain committed to our medium-term financial targets. We continue to forecast ongoing revenue growth of greater than 5% for the Hospitals business. Vita is delivering ahead of plan and newly opened Spire Clinics are sending downstream revenue to nearby Hospitals. Our ambition is for Primary Care to become a >£40m EBITDA business in the medium term, delivered through significant contract wins in Mental Health/Occupational Therapy, more new Clinic openings and small M&A. Combining this together with accelerated savings, we expect to be able to neutralise NI/NMW and payor mix changes fully by 2027, enabling delivery of our medium-term ROCE and Hospital margin targets.

Spire Healthcare has traded in-line with our expectations since the year end.

Justin Ash, CEO of Spire Healthcare, said: "This is a good set of results, delivering all core guidance measures in a changing market. We saw revenue growth of 6.2% year-on-year and adjusted profit before tax growing 29.4%. Market fundamentals remain strong, with private medical insurance coverage growing significantly and a strong partnership with the NHS. Our strategy is delivering. We broadened our range of services to meet more healthcare needs in our hospitals, our clinics, in the community and at home; welcomed more NHS patients and invested significantly in our Hospital staff. We are playing a pivotal role in helping employees stay in work or return to work; all whilst maintaining and improving our quality of care and levels of patient safety, which remain our number one priorities. I thank all our colleagues and consultant partners for their expertise and commitment.

We are excited about the future. We remain confident in the combination of structural market growth, supplemented by the potential of new Primary Care services to complement our hospitals, and a continued strategic partnership with the NHS helping to deliver waiting list reductions. In the year ahead, we will see pressure on costs as a result of National Insurance and Minimum Wage changes. However, we already have a successful efficiencies programme in place and intend to drive self-help measures even faster, partly offsetting the impact to operating costs. I am excited about our prospects for 2025 and we look forward to contributing in even greater measure to the nation's health."
Posted at 11/5/2023 08:43 by bonzo1975
Spire Healthcare Group PLC AGM StatementSource: UK Regulatory (RNS & others)TIDMSPIRNS Number : 0236ZSpire Healthcare Group PLC11 May 2023Spire Healthcare Group plc('Spire Healthcare', 'the Group' or 'the Company')AGM STATEMENT11 May 2023Ahead of its Annual General Meeting later today, Spire Healthcare Group plc (LSE: SPI), a leading independent healthcare group in the UK, provides the following update for the period 1 January 2023 to 30 April 2023.The Board is pleased with the Group's performance during the first four months of the year. Consistent with expectations stated in our FY22 results announcement, good momentum has continued from the end of last year. We reiterate our outlook for the full year, as set out in the same announcement.We expect to announce our results for the six months ending 30 June on 14 September 2023.-Ends-For further information please contact: Spire Healthcare +44 (0)20 7427 9000 Angus Prentice - Director of Investor Relations Instinctif Partners +44 (0)20 7457 2020 Damian ReeceGuy ScarboroughRegistered Office and Head Office:Spire Healthcare Group plc3 Dorset RiseLondonEC4Y 8ENRegistered number: 0 9084066About Spire HealthcareSpire Healthcare is a leading independent healthcare group in the United Kingdom, with 39 hospitals and 33 clinics, medical centres and consulting rooms across England, Wales and Scotland. It operates a network of private GPs and provides occupational health services to over 700 corporate clients.Working in partnership with over 8,760 experienced consultants, Spire Healthcare delivered tailored, personalised care to approximately 926,500 inpatients, outpatients and day-case patients in 2022, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. The Group's well-located and scalable hospitals have delivered successful and award-winning clinical outcomes, positioning the Group well with patients, consultants, the NHS, GPs and Private Medical Insurance (PMI) providers. 98% of Spire Healthcare's inspected hospitals and clinics are rated 'Good', 'Outstanding' or the equivalent by health inspectors in England, Scotland and Wales.This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDAGMSFWEFSEDSESI(END) Dow Jones NewswiresMay 11, 2023 02:00 ET (06:00 GMT)
Spire Healthcare share price data is direct from the London Stock Exchange

Spire Healthcare Frequently Asked Questions (FAQ)

What is the current Spire Healthcare share price?
The current share price of Spire Healthcare is 185.00p
How many Spire Healthcare shares are in issue?
Spire Healthcare has 402,751,824 shares in issue
What is the market cap of Spire Healthcare?
The market capitalisation of Spire Healthcare is GBP 745.09M
What is the 1 year trading range for Spire Healthcare share price?
Spire Healthcare has traded in the range of 168.20p to 270.50p during the past year
What is the PE ratio of Spire Healthcare?
The price to earnings ratio of Spire Healthcare is 29.38
What is the cash to sales ratio of Spire Healthcare?
The cash to sales ratio of Spire Healthcare is 0.49
What is the reporting currency for Spire Healthcare?
Spire Healthcare reports financial results in GBP
What is the latest annual turnover for Spire Healthcare?
The latest annual turnover of Spire Healthcare is GBP 1.51B
What is the latest annual profit for Spire Healthcare?
The latest annual profit of Spire Healthcare is GBP 25.4M
What is the registered address of Spire Healthcare?
The registered address for Spire Healthcare is 3 DORSET RISE, LONDON, EC4Y 8EN
What is the Spire Healthcare website address?
The website address for Spire Healthcare is www.spirehealthcare.com
Which industry sector does Spire Healthcare operate in?
Spire Healthcare operates in the HEALTH & ALLIED SERVICES,NEC sector

Your Recent History

Delayed Upgrade Clock